摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

4-chloro-2-(3,4-dimethylpyrrol-1-yl)benzoic acid | 53592-64-6

中文名称
——
中文别名
——
英文名称
4-chloro-2-(3,4-dimethylpyrrol-1-yl)benzoic acid
英文别名
——
4-chloro-2-(3,4-dimethylpyrrol-1-yl)benzoic acid化学式
CAS
53592-64-6
化学式
C13H12ClNO2
mdl
——
分子量
249.697
InChiKey
SSIJTBDEBJUQCA-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    3.2
  • 重原子数:
    17
  • 可旋转键数:
    2
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.15
  • 拓扑面积:
    42.2
  • 氢给体数:
    1
  • 氢受体数:
    2

上下游信息

  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    4-chloro-2-(3,4-dimethylpyrrol-1-yl)benzoic acid二异丁基氢化铝 作用下, 以 乙醚 为溶剂, 生成 4-chloro-2-(3,4-dimethylpyrrol-1-yl)benzyl alcohol
    参考文献:
    名称:
    ATP-Citrate Lyase as a Target for Hypolipidemic Intervention. 2. Synthesis and Evaluation of (3R*,5S*)-ω-Substituted-3-carboxy-3,5-dihydroxyalkanoic Acids and Their γ-Lactone Prodrugs as Inhibitors of the Enzyme in Vitro and in Vivo
    摘要:
    series of (3R*,5S*)-omega-substituted-3-carboxy-3,5-dihydroxyalkanoic acids have been synthesized and evaluated as inhibitors of the recombinant human form of ATP-citrate lyase. The best of these have K-i's in the 200-1000 nM range. As the corresponding thermodynamically favored gamma-lactone prodrugs, a number of compounds are able to inhibit cholesterol and fatty acid synthesis in HepG2 cells and reduce plasma triglyceride levels in vivo. The best of these, compound 77, is able to induce clear hypocholesterolemic and hypotriglyceridaemic responses when administered orally to rat and dog. These results provide evidence to support the hypothesis that compounds which inhibit ATP-citrate lyase have the potential to be a novel class of hypolipidemic agent, which possess combined hypocholesterolemic and hypotriglyceridemic activities.
    DOI:
    10.1021/jm980091z
  • 作为产物:
    参考文献:
    名称:
    SUGIHARA H.; MATSUMOTO N.; HAMURO Y.; KAWAMATSU Y., ARZNEIMITTEL-FORSCH., 1974, 24, NO 10, 1560-1563
    摘要:
    DOI:
点击查看最新优质反应信息